Testicular cancer statistics

Cases

New cases of testicular cancer, 2011, UK

Deaths

Deaths from testicular cancer, 2012, UK

Survival

Survive testicular cancer for 10 or more years, 2010-11, England and Wales

Prevention

Preventable cases of testicular cancer are not known as it is not clearly linked to any preventable risk factors

  • Testicular cancer is the 16th most common cancer in men in the UK.
  • Around 2,200 men in the UK were diagnosed with testicular cancer in 2011, that is around 6 men every day.
  • Testicular cancer has an unusual relationship with age: it is more common in younger men than in older men.
  • Testicular cancer is rare before puberty but is the most common cancer in men aged 25-49 in the UK.
  • Incidence of testicular cancer has more than doubled in Britain since the mid-1970s, though rates have stabilised in recent years.
  • Worldwide, around 55,300 new cases of testicular cancer were estimated to have been diagnosed in 2012, with incidence rates varying across the world.
  • In Europe, around 21,500 new cases of testicular cancer were estimated to have been diagnosed in 2012. The UK incidence rate is 19th highest in Europe.

Read more in-depth testicular cancer incidence statistics

  • In the UK in 2012 around 60 men died from testicular cancer.
  • Testicular cancer death rates have fallen by around 80% since the early 1970s.
  • Unlike most cancers, more younger men die from testicular cancer compared to older men.
  • Worldwide, around 10,400 men were estimated to have died from testicular cancer in 2012, with mortality rates varying across the world.
  • In Europe, around 1,600 men were estimated to have died from testicular cancer in 2012. The UK mortality rate is eighth lowest in Europe.

Read more in-depth testicular cancer mortality statistics

  • Almost all (98%) men diagnosed with testicular cancer in England and Wales survive their disease for ten years or more (2010-11).
  • Almost all (98%) men diagnosed with testicular cancer in England and Wales survive their disease for five years or more (2010-11).
  • Around all (99%) men diagnosed with testicular cancer in England and Wales survive their disease for one year or more (2010-11).
  • Testicular cancer survival is highest for men diagnosed aged under 50 years old.
  • Almost all men diagnosed aged 15-49 survive their disease for five years or more, compared with half of men diagnosed aged 80 and over.
  • Testicular cancer survival is improving and has increased in the last 40 years in the UK, probably because of combination chemotherapy.
  • In the 1970s, around 7 in 10 men diagnosed with testicular cancer survived their disease beyond ten years, now it's around all men.
  • When diagnosed at its earliest stage, all men with testicular cancer will survive their disease for five years or more, compared with around 8 in 10 men when diagnosed at the latest stage.

Read more in-depth testicular cancer survival statistics

  • Testicular cancer is not clearly linked to any preventable risk factors.
  • A man’s risk of developing testicular cancer depends on many factors, including age,genetics, and exposure to risk factors.
  • No modifiable factors have been conclusively linked with testicular cancer risk, though many factors have been studied. The most well-established risk factor for testicular cancer is cryptorchidism.
  • Certain medical conditions and diethylstilbestrol exposure in utero may relate to higher testicular cancer risk, but evidence is unclear.

Read more in-depth testicular cancer risk factor statistics

Want these Key Stats as a document or looking for a stats report?
Use the print function at the bottom of any page Share this page > +Other > Print or through your browser options to print or save these stats.

The latest statistics available for testicular cancer in the UK are; incidence 2011, mortality 2012 and survival 2010-2011.

The ICD code Open a glossary item for testicular cancer is ICD-10 C62.

Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages Open a glossary item and co-morbidities Open a glossary item. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics.

Survival by stage is not yet routinely available for the UK due to inconsistencies in the collecting and recording of staging data in the past. Survival by stage is available for the former Anglia Cancer Network in the east of England, however. The former Anglia Cancer Network covers around 5% of the population of England and may not be representative of the country as a whole due to differences in underlying demographic factors (such as age, deprivation or ethnicity), as well as variation in local healthcare provision standards and policies.

Meta-analyses Open a glossary item and systematic reviews Open a glossary item are cited where available, as they provide the best overview of all available research and most take study quality into account. Individual case-control and cohort studies are reported where such aggregated data are lacking.

Routes to diagnosis statistics were calculated from cases of cancer registered in England which were diagnosed in 2006-2010.

Cancer waiting times statistics are for patients who entered the health care system within financial year 2014-15. Testicular cancer is part of the group 'Urological cancer' for cancer waiting times data. Codes vary per country but broadly include: penis, prostate, testis, other and unspecified male genital organs, kidney, renal pelvis, ureter, bladder, other and unspecified urinary organs, secondary cancers of kidney, renal pelvis, bladder and other unspecified urinary organs.

Citation

You are welcome to reuse this Cancer Research UK statistics content for your own work.

Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year]. 

Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK. 

Acknowledgements

We would like to acknowledge the essential work of the cancer registries in the United Kingdom and Ireland Association of Cancer Registries, without which there would be no data.

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page